Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Milstein

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Gastroenterology|February 1, 2020
Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-Titer Hepatitis B Virus Carrier MiceThomas Michler, Anna D Kosinska, Julia Festag, et al.
The Journal of Clinical Investigation|April 3, 2012
Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese miceDing Ai, Juan M Baez, Hongfeng Jiang, et al.
Chembiochem : a European Journal of Chemical Biology|March 20, 2015
Hepatocyte-specific delivery of siRNAs conjugated to novel non-nucleosidic trivalent N-acetylgalactosamine elicits robust gene silencing in vivoKallanthottathil G Rajeev, Jayaprakash K Nair, Muthusamy Jayaraman, et al.
Genomics|January 9, 2007
hORFeome v3.1: a resource of human open reading frames representing over 10,000 human genesPhilippe Lamesch, Ning Li, Stuart Milstein, et al.
ACS Chemical Biology|March 3, 2015
siRNA conjugates carrying sequentially assembled trivalent N-acetylgalactosamine linked through nucleosides elicit robust gene silencing in vivo in hepatocytesShigeo Matsuda, Kristofer Keiser, Jayaprakash K Nair, et al.
The Journal of Clinical Investigation|April 28, 2020
RNA interference therapeutics targeting angiotensinogen ameliorate preeclamptic phenotype in rodent modelsNadine Haase, Donald J Foster, Mark W Cunningham, et al.
Biotechnology Progress|November 23, 2012
Evaluation of exogenous siRNA addition as a metabolic engineering tool for modifying biopharmaceuticalsSeshu Tummala, Michael Titus, Lee Wilson, et al.
Molecular Systems Biology|November 6, 2009
Edgetic perturbation models of human inherited disordersQuan Zhong, Nicolas Simonis, Qian-Ru Li, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 2, 2016
Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosisJames S Butler, Amy Chan, Susete Costelha, et al.
Journal of Hepatology|June 8, 2023
Evaluation of RNAi therapeutics VIR-2218 and ALN-HBV for chronic hepatitis B: Results from randomized clinical trialsEd Gane, Young-Suk Lim, Jae B Kim, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Gastroenterology|February 1, 2020
Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-Titer Hepatitis B Virus Carrier MiceThomas Michler, Anna D Kosinska, Julia Festag, et al.
The Journal of Clinical Investigation|April 3, 2012
Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese miceDing Ai, Juan M Baez, Hongfeng Jiang, et al.
Chembiochem : a European Journal of Chemical Biology|March 20, 2015
Hepatocyte-specific delivery of siRNAs conjugated to novel non-nucleosidic trivalent N-acetylgalactosamine elicits robust gene silencing in vivoKallanthottathil G Rajeev, Jayaprakash K Nair, Muthusamy Jayaraman, et al.
Genomics|January 9, 2007
hORFeome v3.1: a resource of human open reading frames representing over 10,000 human genesPhilippe Lamesch, Ning Li, Stuart Milstein, et al.
ACS Chemical Biology|March 3, 2015
siRNA conjugates carrying sequentially assembled trivalent N-acetylgalactosamine linked through nucleosides elicit robust gene silencing in vivo in hepatocytesShigeo Matsuda, Kristofer Keiser, Jayaprakash K Nair, et al.
The Journal of Clinical Investigation|April 28, 2020
RNA interference therapeutics targeting angiotensinogen ameliorate preeclamptic phenotype in rodent modelsNadine Haase, Donald J Foster, Mark W Cunningham, et al.
Biotechnology Progress|November 23, 2012
Evaluation of exogenous siRNA addition as a metabolic engineering tool for modifying biopharmaceuticalsSeshu Tummala, Michael Titus, Lee Wilson, et al.
Molecular Systems Biology|November 6, 2009
Edgetic perturbation models of human inherited disordersQuan Zhong, Nicolas Simonis, Qian-Ru Li, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 2, 2016
Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosisJames S Butler, Amy Chan, Susete Costelha, et al.
Journal of Hepatology|June 8, 2023
Evaluation of RNAi therapeutics VIR-2218 and ALN-HBV for chronic hepatitis B: Results from randomized clinical trialsEd Gane, Young-Suk Lim, Jae B Kim, et al.
Pageof 5